Donate
Join Us

gene replacement

Neurogene doses first two children in gene therapy trial
November 30, 2023
Neurogene Doses First Two Patients in Pediatric US Trial
gene replacement
July 31, 2023
Taysha Cleared to Dose Second Patient in Gene Therapy Trial
gene replacement
June 5, 2023
Taysha Gene Therapies Doses First Rett Syndrome Patient
gene replacement
April 18, 2023
Neurogene Shares Key Information on Gene Therapy Clinical Trial with the Rett Community
gene replacement
February 1, 2023
Taysha Provides Update For Their Rett Syndrome Gene Replacement Program
gene replacement
January 23, 2023
Neurogene Receives FDA Approval for Gene Replacement Clinical Trial for Rett Syndrome
gene replacement
December 19, 2022
What We Accomplished in 2022
gene replacement
December 13, 2022
What We Learned from Taysha’s Clinical Trial Community Update
gene replacement
October 26, 2022
Taysha Gene Therapies Shares Rett Syndrome Community Statement on its Collaboration with Astellas Gene Therapies
gene replacement
October 25, 2022
Taysha Announces Collaboration with Astellas Gene Therapies
gene replacement
July 1, 2022
A Conversation with Neurogene's Leadership
gene replacement
May 18, 2022
Neurogene Advances a Rett Gene Replacement Program that Got Its Start at RSRT
gene replacement
April 14, 2022
Town Hall: When will there be a cure for Rett syndrome?
gene replacement
March 30, 2022
Taysha Gene Therapies Shares Rett Syndrome Community Statement on its Clinical Trial
gene replacement
October 27, 2021
Monica’s Perspective on the Novartis News
gene replacement
October 26, 2021
Novartis Terminates Their Rett Syndrome Gene Replacement Program
gene replacement
September 28, 2021
Outcomes of a Marathon FDA Meeting on the Safety of Gene Replacement
gene replacement
September 24, 2021
Taysha Gene Therapies Shares Letter to the Rett Syndrome Community